Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Safety of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma

NCT01500304 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01500304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01500304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Safety of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2012
Completion date
December 31, 2015
Enrollment
88 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma